Riskpilot← Back to searchSign inGet full accessINDUS AS
ASActiveOrg 990903964Haraldshaugen 2, 1339 VøyenengaGeneral medical practice activities · NACE 8621Est. 20072 employees
Revenue 2025
NOK 28,5M
-8% vs 2024
EBITDA margin
25.6%
+386% vs 2024
Equity ratio
6.6%
Financial strength
Net profit 2025
NOK 1,1M
+109% vs 2024
| Revenue | NOK 28,5M | -8% |
| EBITDA | NOK 7,3M | +386% |
| Net profit | NOK 1,1M | +109% |
| Total assets | NOK 69,2M | -21% |
| Equity | NOK 4,6M | +30% |
| Employees | 2 | — |
Legal name
INDUS AS
Org number
990903964
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
19. februar 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Legevirksomhet. Videre kjøp/salg og drift av fast eiendom, kjøp/salg av aksjer og andre verdipapirer og hva som står i forbindelse med dette.
Address
Haraldshaugen 2, 1339 Vøyenenga
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5 343 | 5 706 | 6 695 | 7 201 | 7 981 | 9 169 | 8 875 | 8 409 | 8 327 | 8 821 | 8 673 | 8 762 | 9 439 | 10 165 | 10 616 | 12 123 | 31 006 | 28 499 |
| Staff expenses | −1 250 | −1 630 | −1 618 | −1 624 | −1 619 | −1 620 | −1 626 | −1 747 | −1 647 | −1 650 | −1 628 | −1 703 | −1 682 | −1 817 | −2 145 | −2 437 | −2 377 | −2 391 |
| EBITDA | 2 703 | 2 550 | 3 446 | 3 162 | 3 526 | 4 400 | 4 230 | 3 984 | 3 407 | 4 419 | 3 833 | 3 926 | 4 877 | 4 871 | 4 463 | 153 | −2 549 | 7 291 |
| Depreciation & amort. | −140 | −219 | −258 | −247 | −328 | −394 | −436 | −498 | −538 | −527 | −486 | −264 | −161 | −117 | −156 | −239 | −247 | −234 |
| EBIT | 2 563 | 2 331 | 3 188 | 2 915 | 3 198 | 4 007 | 3 794 | 3 486 | 2 869 | 3 893 | 3 346 | 3 662 | 4 716 | 4 754 | 4 307 | −87 | −2 796 | 7 057 |
| Net financials | −542 | −271 | −199 | −407 | −226 | −616 | −970 | −825 | −701 | −660 | −849 | −1 321 | −1 607 | −1 854 | −3 270 | −6 914 | −8 959 | −5 986 |
| Profit before tax | 2 021 | 2 060 | 2 989 | 2 508 | 2 972 | 3 391 | 2 825 | 2 661 | 2 168 | 3 233 | 2 498 | 2 341 | 3 109 | 2 901 | 1 036 | −7 001 | −11 755 | 1 072 |
| Tax | 641 | 584 | 843 | 760 | 827 | 963 | 736 | 723 | 556 | 764 | 611 | 510 | 671 | 595 | 223 | 261 | −0 | −0 |
| Net profit | 1 381 | 1 477 | 2 147 | 1 748 | 2 145 | 2 428 | 2 089 | 1 938 | 1 612 | 2 469 | 1 887 | 1 831 | 2 438 | 2 305 | 813 | −7 262 | −11 755 | 1 072 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 043 | 7 263 | 9 945 | 11 163 | 15 358 | 24 040 | 30 077 | 30 931 | 31 441 | 35 935 | 41 184 | 53 922 | 65 287 | 83 422 | 102 306 | 113 908 | 87 250 | 69 206 |
| Equity | 704 | 1 431 | 3 203 | 4 576 | 6 421 | 8 319 | 10 004 | 11 442 | 12 304 | 14 023 | 15 159 | 16 991 | 19 428 | 21 734 | 22 546 | 15 285 | 3 529 | 4 601 |
| Long-term debt | 3 985 | 3 875 | 4 880 | 4 717 | 7 076 | 13 460 | 18 179 | 17 429 | 17 050 | 19 370 | 19 911 | 26 079 | 38 493 | 55 046 | 54 429 | 67 826 | 70 197 | 63 192 |
| Short-term debt | 2 354 | 1 956 | 1 862 | 1 870 | 1 861 | 2 261 | 1 894 | 2 060 | 2 087 | 2 543 | 6 114 | 10 853 | 7 366 | 6 643 | 25 330 | 30 797 | 13 523 | 1 413 |
| Total debt | 6 339 | 5 832 | 6 742 | 6 587 | 8 937 | 15 721 | 20 072 | 19 489 | 19 137 | 21 913 | 26 025 | 36 932 | 45 859 | 61 689 | 79 759 | 98 623 | 83 720 | 64 605 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20082025
Equity ratio
6.6%
This company
38.2%
Market median
-83% vs market
20082025
Return on equity
23.3%
This company
18.4%
Market median
+27% vs market
20082025
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20082025
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20082025
Debt / equity
14.04×
This company
0.62×
Market median
-2165% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GS Chief Executive Officer | Chief Executive Officer | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2007 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
INDUS AS 
GULSKOGEN LEGESENTER ASBoard members of INDUS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gurkirpal Singh | Chief Executive Officer | 0 companies |
| Manjit Kaur | Chairman | 0 companies |